Author:
Dunn Colin P.,Zhao Jasmine,Wang Jennifer C.,Patel Tanu A.,Putnam Luke R.,Eka Aleeson,Houghton Caitlin C.,Bildzukewicz Nikolai A.,Lipham John C.
Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. Richter JE, Rubenstein JH (2018) Presentation and epidemiology of gastroesophageal reflux disease. Gastroenterology 154:267–276
2. Reynolds JL, Zehetner J, Bildzukewicz N, Katkhouda N, Dandekar G, Lipham JC (2014) Magnetic sphincter augmentation with the LINX device for gastroesophageal reflux disease after U.S. Food and Drug Administration approval. Am Surg 80:1034–1038
3. Hillman L, Yadlapati R, Thuluvath AJ, Berendsen MA, Pandolfino JE (2017) A review of medical therapy for proton pump inhibitor nonresponsive gastroesophageal reflux disease. Dis Esophagus 30:1–15
4. Azzam RS (2018) Are the persistent symptoms to proton pump inhibitor therapy due to refractory gastroesophageal reflux disease or to other disorders? Arq Gastroenterol 55(Suppl 1):85–91
5. Scarpellini E, Ang D, Pauwels A, De Santis A, Vanuytsel T, Tack J (2016) Management of refractory typical GERD symptoms. Nat Rev Gastroenterol Hepatol 13:281–294
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献